Status epilepticus induces cardiac myofilament damage and increased susceptibility to arrhythmias in rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 6, 2009, Pages

  Metcalf, Cameron S ^a   Poelzing, Steven ^b   Little, Jason G ^a   Bealer, Steven L ^a  

^a UNIVERSITY OF UTAH   (United States)

^b Department of Electrical and Computer Engineering   (United States)

Author keywords

Cardiomyocyte; QT dispersion; QT interval corrected for heart rate; Seizures; Troponin I

Indexed keywords

ACONITINE; BIOTIN; DNA NUCLEOTIDYLEXOTRANSFERASE; VALPROIC ACID;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELECTRIC ACTIVITY; ELECTROCARDIOGRAPHY; EPILEPTIC STATE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE PRESSURE; MALE; MYOFILAMENT; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; QT DISPERSION; QT PROLONGATION; RAT;

ACONITINE; ACTION POTENTIALS; ANIMALS; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ELECTROCARDIOGRAPHY; HEART RATE; IN SITU NICK-END LABELING; LITHIUM CHLORIDE; MALE; MICROFILAMENTS; MYOCARDIUM; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; TROPONIN I;

EID: 72249093535     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00724.2009     Document Type: Article

References (68)

1. Akashi YJ, Nef HM, Möllmann H, Ueyama T. Stress cardiomyopathy. Annu Rev Med. In press.
2. Antman EM. Decision making with cardiac troponin tests. N Engl J Med 346: 2079-2082, 2002.
3. Benowitz NL, Simon RP, Copeland JR. Status epilepticus: divergence of sympathetic activity and cardiovascular response. Ann Neurol 19: 197-199, 1986.
4. Bernstein R, Mayer SA, Magnano A. Neurogenic stunned myocardium in Guillain-Barré syndrome. Neurology 54: 759-762, 2000. (Pubitemid 30082957)
5. Boggs JG, Marmarou A, Agnew JP, Morton LD, Towne AR, Waterhouse EJ, Pellock JM, DeLorenzo RJ. Hemodynamic monitoring prior to and at the time of death in status epilepticus. Epilepsy Res 31: 199-209, 1998. (Pubitemid 28370846)
6. Bolli R. Mechanisms of myocardial "stunning." Circulation 82: 173-738, 1990.
7. Bolli R. Myocardial "stunning" in man. Circulation 86: 1671-1691, 1992.
8. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79: 609-634, 1999. (Pubitemid 29210931)
9. Britt JO, Martin JL, Okerberg CV, Dick EJ Jr. Histopathologic changes in brain, heart, and skeletal muscle of rhesus macaques, ten days after exposure to soman (an organophosphorus nerve agent). Comp Med 50: 133-139, 2000.
10. Bulsara KR, Mcgirt MJ, Liao L, Villavicencio AT, Borel C, Alexander MJ, Friedman AH. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg 98: 524-528, 2003. (Pubitemid 36262772)
11. Chalmers J, Arnolda L, Llewellyn-Smith I, Minson J, Pilowsky P, Suzuki S. Central neurons and neurotransmitters in the control of blood pressure. Clin Exp Pharmacol Physiol 21: 819-829, 1994. (Pubitemid 24348662)
12. Chalmers J, Pilowsky P. Brainstem and bulbospinal neurotransmitter systems in control of blood pressure. J Hypertens 9: 675-694, 1991.
13. Chen L, Wang L, Xu B, Ni G, Yu L, Han B, Yu X, Wang K, Lai Y, Zhou S, Zhu Q. Mechanisms of alpha1-adrenoceptor mediated QT prolongation in the diabetic rat heart. Life Sci 84: 250-256, 2009.
14. Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol 11: 800-810, 2004. (Pubitemid 39665056)
15. Chuang CP, Chao CL. Neurogenic stunned myocardium in a patient with metastatic brain tumors. Int J Cardiol 76: 251-253, 2000.
16. Chugh SS, Reiner K, Singh T, Uy-Evanado A, Socoteanu C, Peters D, Mariani R, Gunson K, Jui J. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: The Oregon sudden unexpected death study. Circulation 119: 663-670, 2009.
17. da Silva Costa EC, Concalves AA, Areas MA, Morgabel RG. Effects of meformin on QT and QTc interval dispersion in diabetic rats. Arq Bras Cardiol 90: 232-238, 2008.
18. Darbar D, Luck J, Davidson N, Pringle T, Main G, McNeill G, Struthers AD. Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. BMJ 312: 874-878, 1996. (Pubitemid 126443429)
19. de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation 97: 467-472, 1998. (Pubitemid 28090219)
20. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D. A prospective population based epidemiological study of status epilepticus in Richmond, Virginia. Neurology 46: 1029-1035, 1996. (Pubitemid 26134646)
21. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 12: 316-325, 1995.
22. DeLorenzo RJ, Towne AR, Pellock JM, Ko D. Status epilepticus in children, adults and the elderly. Epilepsia 33, Suppl 4: S15-S25, 1992.
23. Denney SD, Lakkireddy DR, Khan IA. Long QT syndrome and torsade de pointes in transient left ventricular apical ballooning syndrome. Int J Cardiol 100: 499-501, 2005. (Pubitemid 40503300)
24. Donaldson JW, Pritz MB. Myocardial stunning secondary to aneurysmal subarachnoid hemorrhage. Surg Neurol 55: 12-16, 2001. (Pubitemid 32186349)
25. 2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ Res 76: 1036-1048, 1995.
26. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
27. Glien M, Brandt C, Potschka H, Voigt H, Ebert U, Löscher W. Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy. Epilepsy Res 46: 111-119, 2001. (Pubitemid 32709924)
28. Grippo AJ, Santos CM, Johnson RF, Beltz TG, Martins JB, Felder RB, Johnson AK. Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression. Am J Physiol Heart Circ Physiol 286: H619-H626, 2004.
29. Hitiris N, Mohanraj R, Norrie J, Brodie MJ. Mortality in epilepsy. Epilepsy Behav 10: 363-376, 2007.
30. Iga K, Himura Y, Izumi C, Miyamoto T, Kijima K, Gen H, Konishi T. Reversible left ventricular dysfunction associated with Guillain-Barré syndrome - an expression of catecholamine cardiotoxicity? Jpn Circ J 59: 236-240, 1995.
31. Jones DM, Esmaeil N, Maren S, Macdonald L. Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res 50: 301-312, 2002. (Pubitemid 35015214)
32. Kanter RK, Erickson JT, Millhorn DE. Activation of the c-fos gene in prodynorphin- and proenkephalin-expressing cells of the nucleus tractus solitarius after seizures. Exp Neurol 129: 290-298, 1991.
33. Kanter RK, Strauss JA, Sauro MD. Comparison of neurons in rat medulla oblongata with fos immunoreactivity evoked by seizures, chemoreceptor, or baroreceptor stimulation. Neuroscience 73: 807-816, 1996.
34. Kanter RK, Strauss JA, Sauro MD. Seizure-induced c-fos expression in rat medulla oblongata is not dependent on associated elevation of blood pressure. Neurosci Lett 194: 201-204, 1995.
35. Klekot AA. Antiarrhythmic activity of a membrane-protecting agent Sal'magin in rats with aconitine-induced arrhythmias. Bull Exp Biol Med 142: 209-211, 2006.
36. Kloner RA, Bolli R, Marban E, Reinlib L, Braunwald E. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation 97: 1848-1867, 1998.
37. Kloner RA, Jennings DB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications. Circulation 104: 3158-3167, 2001. (Pubitemid 34014074)
38. Kreisman NR, Gauthier-Lewis ML, Conklin SG, Voss NF, Barbee RW. Cardiac output and regional hemodynamics during recurrent seizures in rats. Brain Res 626: 295-302, 1993.
39. Kulkarni SK, George B. Lithium-pilocarpine neurotoxicity: a potential model of status epilepticus. Methods Find Exp Clin Pharamacol 17: 551-567, 1995.
40. Kurata M, Iidaka T, Sasayama Y, Fukushima T, Sakimura M, Shirai N. Correlation among clinicopathological parameters of myocardial damage in rats treated with isoproterenol. Exp Anim 56: 57-62, 2007. (Pubitemid 46358583)
41. Lee VH, Oh JK, Mulvagh SL, Wijdicks EF. Mechanisms of neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care 5: 243-249, 2006. (Pubitemid 46244153)
42. Legriel S, Bruneel F, Dalle L, Appere-de-Vecchi C, Georges JL, Abbosh N, Henry-Lagarrigue M, Revault D'Allonnes L, Ben Mokhtar H, Audibert J, Guezennec P, Troche G, Bedos JP. Recurrent takotsubo cardiomyopathy triggered by convulsive status epilepticus. Neurocrit Care 9: 118-121, 2008.
43. Legriel S, Mourvillier B, Bele N, Amaro J, Fouet P, Manet P, Hilpert F. Outcomes of 140 critically ill patients with status epilepticus. Intensive Care Med 34: 476-480, 2008.
44. Logroscino G, Hesdorffer DC, Cascino G, Hauser WA, Coeytaux A, Glalobardes B, Morabia A, Jallon P. Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia 46: 46-48, 2005. (Pubitemid 44922038)
45. Manno EM, Pfeifer EA, Cascino GD, Noe KH, Wijdicks EF. Cardiac pathology in status epilepticus. Ann Neurol 58: 954-957, 2005.
46. McDonough JH, Dochterman LW, Smith CD, Shih TM. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 16: 123-132, 1995.
47. Nyska A, Murphy E, Foley JF, Collins BJ, Petranka J, Howden R, Hanlon P, Dunnick JK. Acute hemorrhagic myocardial necrosis and sudden death of rats exposed to a combination of ephedrine and caffeine. Toxicol Sci 83: 388-396, 2005. (Pubitemid 40227909)
48. O'Brien PJ, Smith DE, Knechtel TJ, Marchak MA, Pruimboom-Brees I, Brees DJ, Spratt DP, Archer FJ, Butler P, Potter AN, Provost JP, Richard J, Snyder PA, Reagan WJ. Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim 40: 153-171, 2006.
49. Painter JA, Shiel FO, DeLorenzo RJ. Cardiac pathology findings in status epilepticus (Abstract). Epilepsia 34, Suppl 6: 30, 1993.
50. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor Seizure. Electroencephalogr Clin Neurophysiol 32: 281-294, 1972.
51. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus. Arch Neurol 62: 1968-11702, 2005.
52. Sakamoto K, Saito T, Orman R, Koizumi K, Lazar J, Salciccioli L, Stewart M. Autonomic consequences of kainic acid-induced limbic cortical seizures in rats: peripheral autonomic nerve activity, acute cardiovascular changes, and death. Epilepsia 49: 982-996, 2008. (Pubitemid 351794001)
53. Sarko J, Pollack CV Jr. Cardiac troponins. J Emerg Med 23: 57-65, 2002.
54. Sato K, Masuda T, Izumi T. Subarachnoid hemorrhage and myocardial damage: clinical and experimental studies. Jpn Heart J 40: 683-701, 1999. (Pubitemid 30128794)
55. Shimizu M, Kagawa A, Takano T, Masai H, Miwa Y. Neurogenic stunned myocardium associated with status epilepticus and postictal catecholamine surge. Intern Med 47: 269-273, 2008.
56. Shu H, Yi-Ming W, Xu LP, Miao CY, Su DF. Increased susceptibility of ventricular arrhythmias to aconitine in anaesthetized rats in attributed to the inhibition of baroreflex. Clin Exp Pharmacol Physiol 31: 249-253, 2004. (Pubitemid 38507866)
57. Singer AW, Jaax NK, Graham JS, McLeod CG. Cardiomyopathy in Soman and Sarin intoxicated rats. Toxicol Lett 36: 2432-12249, 1987.
58. St-Pierre LS, Persinger MA. Extreme obesity in female rats following prepubertal induction of lithium-pilocarpine seizures and a single injection of acepromazine. Epilepsy Behav 7: 411-418, 2005.
59. Takahara A, Uneyama H, Sasaki N, Ueda H, Dohmoto H, Shoji M, Hara Y, Nakaya H, Yoshimoto R. Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmias and cardiac membrane currents. J Cardiovasc Pharmacol 33: 625-632, 1999. (Pubitemid 29164827)
60. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 35: 27-34, 1994.
61. Tryphonas L, Veinot JP, Clement JG. Early histopathological and ultrastructural changes in the heart of Sprague-Dawley rats following administration of soman. Toxicol Pathol 24: 190-198, 1996. (Pubitemid 26107408)
62. + currents among the left ventricular free wall of rats with ascending aortic stenosis. J Physiol 530: 443-455, 2001.
63. Wakisaka Y, Niwano S, Niwano H, Saito J, Yoshida T, Hirasawa S, Kawada H, Izumi T. Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure. Cardiovasc Res 63: 689-699, 2004. (Pubitemid 39078683)
64. Walker M. Status epilepticus: an evidence based guide. BMJ 331: 673-677, 2005. (Pubitemid 41374843)
65. Walton NY. Systemic effects of generalized convulsive status epilepticus. Epilepsia 34, Suppl 1: S54-S58, 1993. (Pubitemid 23108000)
66. Wang TD, Wu CC, Lee YT. Myocardial stunning after cerebral infarction. Int J Cardiol 58: 308-311, 1997.
67. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352: 539-548, 2005. (Pubitemid 40204667)
68. Young RS, Fripp RR, Yagel SK, Werner JC, McGrath JC, Schuler GC. Cardiac dysfunction during status epilepticus in the neonatal pig. Ann Neurol 18: 291-297, 1985.